[{"address1": "677 N. Washington Boulevard", "city": "Sarasota", "state": "FL", "zip": "34236", "country": "United States", "phone": "718 400 9031", "website": "https://silopharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Silo Pharma. Inc., a developmental stage biopharmaceutical company, develops traditional therapeutics and psychedelic medicine. Its lead program includes SPC-15, an intranasal drug targeting post-traumatic stress disorder (PTSD) and stress-induced anxiety disorders; and SP-26, a ketamine-based loaded implant indicated for fibromyalgia and chronic pain relief. The company's preclinical products include SPC-14 to treat Alzheimer's disease; and SPU-16, a central nervous system homing peptide targeting the central nervous system with indication in multiple sclerosis. It also seeks to acquire and/or develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin and ketamine, as well as depression, mental health issues, and neurological disorders. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. Eric  Weisblum", "age": 53, "title": "Chairman, President & CEO", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 569009, "exercisedValue": 0, "unexercisedValue": 8610}, {"maxAge": 1, "name": "Mr. Daniel E. Ryweck", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 62692, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James S. Kuo M.B.A., M.D.", "age": 58, "title": "Vice President of Research & Development", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.18, "open": 1.18, "dayLow": 1.05, "dayHigh": 1.25, "regularMarketPreviousClose": 1.18, "regularMarketOpen": 1.18, "regularMarketDayLow": 1.05, "regularMarketDayHigh": 1.25, "beta": 1.481, "forwardPE": -1.6571429, "volume": 987150, "regularMarketVolume": 987150, "averageVolume": 247404, "averageVolume10days": 434140, "averageDailyVolume10Day": 434140, "bid": 1.1, "ask": 1.21, "bidSize": 100, "askSize": 100, "marketCap": 4276664, "fiftyTwoWeekLow": 1.047, "fiftyTwoWeekHigh": 3.05, "priceToSalesTrailing12Months": 59.314083, "fiftyDayAverage": 1.88996, "twoHundredDayAverage": 1.678505, "currency": "USD", "enterpriseValue": -3492194, "floatShares": 2505274, "sharesOutstanding": 3686780, "sharesShort": 107218, "sharesShortPriorMonth": 115029, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0382, "heldPercentInsiders": 0.04894, "heldPercentInstitutions": 0.0306, "shortRatio": 0.4, "shortPercentOfFloat": 0.040799998, "impliedSharesOutstanding": 2850900, "bookValue": 1.868, "priceToBook": 0.620985, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -3526354, "trailingEps": -1.17, "forwardEps": -0.7, "lastSplitFactor": "1:50", "lastSplitDate": 1663200000, "enterpriseToRevenue": -48.434, "52WeekChange": -0.5115789, "SandP52WeekChange": 0.23232913, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "SILO", "underlyingSymbol": "SILO", "shortName": "Silo Pharma, Inc.", "longName": "Silo Pharma, Inc.", "firstTradeDateEpochUtc": 1610116200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "e5777432-809b-362d-a689-efb776f88c93", "messageBoardId": "finmb_129249050", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.16, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 6744122, "totalCashPerShare": 2.406, "quickRatio": 7.72, "currentRatio": 7.872, "totalRevenue": 72102, "revenuePerShare": 0.024, "returnOnAssets": -0.27355, "returnOnEquity": -0.47861, "freeCashflow": -2115192, "operatingCashflow": -3369989, "grossMargins": 0.91903, "operatingMargins": -48.791363, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-10"}]